These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2650111)

  • 21. Different mechanisms of rejection of organ and cell allografts.
    Olszewski WL; Jasklowska-Englisz M; Lukomska B
    Transplant Proc; 1996 Dec; 28(6):3444-6. PubMed ID: 8962343
    [No Abstract]   [Full Text] [Related]  

  • 22. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
    Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
    J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does endotoxin accelerate rejection in a cardiac allograft model?
    Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
    Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
    [No Abstract]   [Full Text] [Related]  

  • 28. Portal tolerance in rats: effect of donor cell treatment and timing of administration.
    Tanigawa T; Monden M; Nagano H; Hasuike Y; Gotoh M; Fukuzaki T; Ota H; Yoshida T; Mori T
    Transplant Proc; 1994 Aug; 26(4):1870-1. PubMed ID: 8066608
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):286-8. PubMed ID: 8438302
    [No Abstract]   [Full Text] [Related]  

  • 30. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction and mechanisms of unresponsiveness in a rat renal allograft model after recipient pretreatment with specific antigen and cyclosporin and donor pretreatment with irradiation and cyclophosphamide.
    Müller GH; Greger B; Schareck W; Hopt UT; Lauchart W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):385-7. PubMed ID: 2650155
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 33. Why are lung allografts more vigorously rejected than hearts?
    Prop J; Kuijpers K; Petersen AH; Bartels HL; Nieuwenhuis P; Wildevuur CR
    J Heart Transplant; 1985; 4(4):433-6. PubMed ID: 3916517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock protein reactivity of lymphocytes isolated from heterotopic rat cardiac allografts.
    Moliterno R; Valdivia L; Pan F; Duquesnoy RJ
    Transplantation; 1995 Feb; 59(4):598-604. PubMed ID: 7878764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte subsets in heart allograft rejection in a rat model: effect of in vitro generated suppressor cells.
    Lowry RP; Shadur CA; Duarte A; Strom TB; Carpenter CB
    Transplant Proc; 1981 Jun; 13(2):1428-31. PubMed ID: 6454287
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation.
    Hayashi S; Ito M; Yasutomi M; Namii Y; Yokoyama I; Uchida K; Takagi H
    J Heart Lung Transplant; 1995; 14(3):579-84. PubMed ID: 7544621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic heart transplantation activates alloreactive NK cells.
    Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
    Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.